GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lupin Ltd (BOM:500257) » Definitions » Price-to-Free-Cash-Flow

Lupin (BOM:500257) Price-to-Free-Cash-Flow : N/A (As of May. 13, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Lupin Price-to-Free-Cash-Flow?

As of today (2024-05-13), Lupin's share price is ₹1687.75. Lupin's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00. Hence, Lupin's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Lupin's Price-to-Free-Cash-Flow or its related term are showing as below:

BOM:500257' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 0   Med: 0   Max: 193.03
Current: 27.07

During the past 13 years, Lupin's highest Price-to-Free-Cash-Flow Ratio was 193.03. The lowest was 0.00. And the median was 0.00.

BOM:500257's Price-to-Free-Cash-Flow is ranked worse than
55.78% of 502 companies
in the Drug Manufacturers industry
Industry Median: 22.695 vs BOM:500257: 27.07

Lupin's Free Cash Flow per Share for the three months ended in Mar. 2024 was ₹0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ₹0.00.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Lupin was 583.60% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 33.30% per year.

During the past 13 years, Lupin's highest 3-Year average Free Cash Flow per Share Growth Rate was 396.90% per year. The lowest was -87.50% per year. And the median was 21.10% per year.


Lupin Price-to-Free-Cash-Flow Historical Data

The historical data trend for Lupin's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lupin Price-to-Free-Cash-Flow Chart

Lupin Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.73 40.62 - 74.47 27.20

Lupin Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.47 - - - 27.20

Competitive Comparison of Lupin's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Lupin's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lupin's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lupin's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Lupin's Price-to-Free-Cash-Flow falls into.



Lupin Price-to-Free-Cash-Flow Calculation

Lupin's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=1687.75/0
=N/A

Lupin's Share Price of today is ₹1687.75.
Lupin's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Lupin  (BOM:500257) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Lupin Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Lupin's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Lupin (BOM:500257) Business Description

Traded in Other Exchanges
Address
Off. Western Express Highway, 3rd floor, Kalpataru Inspire, Santacruz (East), Mumbai, MH, IND, 400 055
Lupin Ltd is a specialty and generic drug manufacturing company. The company's global formulations business develops and delivers a wide range of branded and generic formulations across the globe. The operations of the company are limited to one segment, namely pharmaceuticals and related products. The company also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India.

Lupin (BOM:500257) Headlines

No Headlines